Science & Innovation
R&D Expertise
Research and Development (R&D) Standard of Excellence
Biogen R&D is driven by the potential to transform the lives of patients. We work in disease areas with some of the greatest unmet need. We work relentlessly, knowing that bold new possibilities await discovery. As a leading global biotechnology company, we work toward those once-in-a-lifetime moments that could become a historic point in our pursuit of innovative treatments.
Disease Areas
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases
Modalities
With capabilities in multiple drug modalities, including small molecules, protein therapeutics, antisense oligonucleotides (ASOs) and gene therapy, Biogen pursues the most appropriate modality for each target.
Small molecules
Often taken orally as a pill and can readily distribute into cells and tissues.
Protein Therapeutics (Biologics)
Allow targeting of serious diseases in ways that might not be possible with other technologies.
Antisense Oligonucleotides (ASOs)
Alter RNA and either resore desired protein expression or reduce and modify toxic proteins.
Gene therapy
Target the root causes of genetic diseases.
Partner With Us
We welcome the opportunity to explore working with other innovators. If your company or institution would like to share a potential asset or platform technology for collaboration, contact us today.
Biogen-229000 | Date of preparation: January 2024